These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9352591)

  • 1. Questions about NOD mouse diabetes.
    Cohen IR
    Res Immunol; 1997 Jun; 148(5):286-91. PubMed ID: 9352591
    [No Abstract]   [Full Text] [Related]  

  • 2. Maintaining or breaking CD8+ T-cell tolerance to beta islet cell antigens: lessons from transgenic mouse models.
    Piaggio E; Hartemann-Heurtier A; Cabarrocas J; Desbois S; Mars LT; Zappulla JP; Liblau RS
    J Autoimmun; 2004 Mar; 22(2):115-20. PubMed ID: 14987739
    [No Abstract]   [Full Text] [Related]  

  • 3. CD4+ and CD8+ T lymphocytes: clarification of their pathogenic roles in diabetes in the NOD mouse.
    Kay TW; Chaplin HL; Parker JL; Stephens LA; Thomas HE
    Res Immunol; 1997 Jun; 148(5):320-7. PubMed ID: 9352596
    [No Abstract]   [Full Text] [Related]  

  • 4. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
    Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
    Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker.
    Lejon K; Fathman CG
    J Immunol; 1999 Nov; 163(10):5708-14. PubMed ID: 10553102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell receptor-transgenic NOD mice: a reductionist approach to understand autoimmune diabetes.
    Yang Y; Santamaria P
    J Autoimmun; 2004 Mar; 22(2):121-9. PubMed ID: 14987740
    [No Abstract]   [Full Text] [Related]  

  • 7. Defects in deletional tolerance of CD8+ T cells in autoimmune diabetes.
    Kreuwel HT; Sherman LA
    Curr Dir Autoimmun; 2001; 4():123-43. PubMed ID: 11569400
    [No Abstract]   [Full Text] [Related]  

  • 8. Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirement for CD8 T-cells.
    Peterson JD; Haskins K
    Diabetes; 1996 Mar; 45(3):328-36. PubMed ID: 8593938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced expression of CD44 isoforms in nonobese diabetic (NOD) mice.
    Milde KF; Alejandro R; Pastori RL
    Transplant Proc; 1995 Dec; 27(6):3409. PubMed ID: 8540022
    [No Abstract]   [Full Text] [Related]  

  • 10. Autoimmune disease. Gadding around the beta cell.
    Cooke A
    Curr Biol; 1994 Feb; 4(2):158-60. PubMed ID: 7953521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions.
    Graser RT; DiLorenzo TP; Wang F; Christianson GJ; Chapman HD; Roopenian DC; Nathenson SG; Serreze DV
    J Immunol; 2000 Apr; 164(7):3913-8. PubMed ID: 10725754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel function of islet-derived CD8+T cells in initiating and developing autoimmune insulin-dependent diabetes mellitus in non-obese diabetic (NOD) mice.
    Amano K; Yokono K; Hasegawa Y; Taki T; Tominaga Y; Yoneda R; Nagata M; Kasuga M
    Diabetes Res Clin Pract; 1995 Jun; 28(3):161-72. PubMed ID: 8529494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idd9.2 and Idd9.3 protective alleles function in CD4+ T-cells and nonlymphoid cells to prevent expansion of pathogenic islet-specific CD8+ T-cells.
    Hamilton-Williams EE; Wong SB; Martinez X; Rainbow DB; Hunter KM; Wicker LS; Sherman LA
    Diabetes; 2010 Jun; 59(6):1478-86. PubMed ID: 20299469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic requirements for acceleration of diabetes in non-obese diabetic mice expressing interleukin-2 in islet beta-cells.
    Allison J; McClive P; Oxbrow L; Baxter A; Morahan G; Miller JF
    Eur J Immunol; 1994 Oct; 24(10):2535-41. PubMed ID: 7925581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-10 impacts autoimmune diabetes via a CD8+ T cell pathway circumventing the requirement for CD4+ T and B lymphocytes.
    Balasa B; Davies JD; Lee J; Good A; Yeung BT; Sarvetnick N
    J Immunol; 1998 Oct; 161(8):4420-7. PubMed ID: 9780221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of vasostatin-1-specific CD8(+) T cells in non-obese diabetic mice that contribute to diabetes pathogenesis.
    Nikoopour E; Krougly O; Lee-Chan E; Haeryfar SM; Singh B
    Clin Exp Immunol; 2016 Sep; 185(3):292-300. PubMed ID: 27185276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal relationship between immune cell influx and the expression of inducible nitric oxide synthase, interleukin-4 and interferon-gamma in pancreatic islets of NOD mice following adoptive transfer of diabetic spleen cells.
    Reddy S; Karanam M; Krissansen G; Nitschke K; Neve J; Poole CA; Ross JM
    Histochem J; 2000 Apr; 32(4):195-206. PubMed ID: 10872884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NOD mouse.
    Bach JF; Mathis D
    Res Immunol; 1997 Jun; 148(5):285-6. PubMed ID: 9352590
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of idd congenic mice to identify checkpoints of peripheral tolerance to islet antigen.
    Hamilton-Williams EE; Martinez X; Lyman M; Hunter K; Wicker LS; Sherman LA
    Ann N Y Acad Sci; 2007 Apr; 1103():118-27. PubMed ID: 17376833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of lymphocyte subsets in accelerated diabetes in nonobese diabetic-rat insulin promoter-B7-1 (NOD-RIP-B7-1) mice.
    Wong FS; Visintin I; Wen L; Granata J; Flavell R; Janeway CA
    J Exp Med; 1998 Jun; 187(12):1985-93. PubMed ID: 9625758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.